STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Geron EVP files Form 3, reports 10,000 directly owned shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Geron Corporation (GERN) executive Ahmed ElNawawi filed a Form 3 initial statement of beneficial ownership. The filing reports 10,000 shares of common stock beneficially owned directly.

ElNawawi serves as EVP, Chief Commercial Officer. The date of the event requiring the statement is 10/20/2025. Table II shows no derivative securities listed in this filing.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
ElNawawi Ahmed

(Last) (First) (Middle)
C/O GERON CORPORATION
919 E. HILLSDALE BLVD, SUITE 250

(Street)
FOSTER CITY CA 94404

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/20/2025
3. Issuer Name and Ticker or Trading Symbol
GERON CORP [ GERN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Commercial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 10,000 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
EX-24 POA
/s/ Scott A. Samuels for Ahmed ElNawawi 10/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Geron (GERN) disclose in this Form 3?

A new executive ownership filing reporting 10,000 shares of Geron common stock beneficially owned directly by Ahmed ElNawawi.

Who is the reporting person in Geron’s Form 3?

Ahmed ElNawawi, EVP, Chief Commercial Officer of Geron Corporation.

How many Geron (GERN) shares does the executive report owning?

The filing lists 10,000 shares of common stock, owned directly.

When is the event date for this ownership report?

The date of the event requiring the statement is 10/20/2025.

Are any derivative securities reported in this Form 3 for GERN?

No. Table II shows no derivative securities listed in the filing.
Geron Corp

NASDAQ:GERN

GERN Rankings

GERN Latest News

GERN Latest SEC Filings

GERN Stock Data

810.71M
634.54M
0.09%
81.97%
13.88%
Biotechnology
Pharmaceutical Preparations
Link
United States
FOSTER CITY